Top Markets
#1 TENDIES TENDIES +51.01%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +50.80%
#3 PondCoin PondCoin +47.39%
#4 Pons Pons +47.05%
#5 StonkBroker StonkBroker +32.47%
#6 Magma Finance Magma Finance +31.63%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#8 SkyAI SkyAI +29.28%
#9 Purr Purr +27.18%
#10 Starpower Starpower +26.87%
Coin of the day
TENDIES TENDIES
Innstillinger
Språk
NORSK
Valuta
USD
Tema
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Rangering i aksjer #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Aksjekurs
$0.04406501
Sist synkronisert: 2024-07-09
Markedsverdi
$23.47M
Endring (1 dag)
-0.48%
Endring (1 år)
0.00%
Land
SE
Handel InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

Healthcare
Inntekter for InDex Pharmaceuticals Holding AB (publ) (INDEX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til InDex Pharmaceuticals Holding AB (publ) er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for InDex Pharmaceuticals Holding AB (publ) fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH